Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Stockholders Deficit (Unaudited)

v3.8.0.1
Condensed Consolidated Statements of Stockholders Deficit (Unaudited) - 3 months ended Mar. 31, 2018 - USD ($)
Common Stock [Member]
Additional Paid-in Capital [Member]
Common Stock Issuable [Member]
Accumulated Deficit [Member]
Total
Balance at Dec. 31, 2017 $ 11,912 $ 22,738,574 $ 430 $ (28,539,953) $ (5,789,037)
Balance, shares at Dec. 31, 2017 119,118,513        
Common shares issued upon exercise of warrants $ 101 21,899 22,000
Common shares issued upon exercise of warrants, shares 1,011,856        
Derivative liability extinguished upon exercise of warrants 723,037 723,037
Proceeds from sale of common stock $ 1,641 2,276,859 $ 2,278,500
Proceeds from sale of common stock, shares 16,409,067       1,679,276
Fair value of common shares issued for services $ 475 3,269,722 (450) $ 3,269,747
Fair value of common shares issued for services, shares 4,748,514        
Fair value of common stock issued upon conversion of debt $ 738 2,276,561 $ 2,277,299
Fair value of common stock issued upon conversion of debt, shares 7,383,006       1,026,195
Fair value of common stock issued upon conversion of accrued officer's salary $ 41 582,292 $ 582,333
Fair value of common stock issued upon conversion of accrued officer's salary, shares 407,226        
Common shares issued upon exercise of put option $ 305 999,695 $ 1,000,000
Common shares issued upon exercise of put option, shares 3,048,105      
Fair value of vested stock options 1,341,207 $ 1,341,207
Net loss (8,494,418) (8,494,418)
Balance at Mar. 31, 2018 $ 15,213 $ 34,229,846 $ (20) $ (37,034,371) $ (2,789,332)
Balance, shares at Mar. 31, 2018 152,126,287